Global Competition Review

DOJ conditionally clears Anheuser-Busch/Craft Brew Alliance

The Department of Justice has approved Anheuser-Busch InBev’s full purchase of Crew Brew Alliance on the condition that the companies divest one of the alliance’s brands in Hawaii.

Ex-JPMorgan trader receives eight-month sentence

Former JPMorgan Chase trader Akshay Aiyer has been sentenced to eight months in federal prison following his conviction on one count of conspiring to fix prices and rig bids for certain currencies.

Tipline

RBG: The Tipline for 21 September 2020
Supreme Court Justice Ruth Bader Ginsburg died on Friday at the age of 87. While not particularly vocal on antitrust, Ginsburg will be remembered for advancing gender equality under the law and also blazing a path for a future generation of lawyers. “I'm sometimes asked, 'When will there be enough [women on the Supreme Court]?' and I say 'When there are nine,’” she once said.
John Pierpont Morgan: The Tipline for 18 September 2020
Rest and relaxation: The Tipline for 17 September 2020

FTC witnesses defend product market in healthcare merger challenge

Witnesses called by the Federal Trade Commission on Tuesday substantiated the agency’s market definition in its challenge to Jefferson Health’s acquisition of Albert Einstein Healthcare Network.

Judge dismisses hiQ antitrust claims, but gives time to amend

LinkedIn has successfully moved to dismiss antitrust claims made by data analytics firm hiQ Labs in the long-running scraping litigation between the two parties – but the business networking site must still …

NY AG: Abuse of dominance standard necessary to bolster weak laws

Competition enforcers need more flexible laws for challenging anticompetitive conduct, New York State attorney general Letitia James has said.

USA Analysis

A little smoke, but no fire

How does a federal enforcer protect competition in a federally illegal market? As cannabis transitions from an unlawful substance to a prescribed medical treatment and recreational drug now legal in several states, Spencer Parts examines how the Department of Justice’s antitrust division has been policing the fledgling industry.

Analysis: Lamictal highlights increased class action scrutiny in pharma cases

The US Court of Appeals for the Third Circuit on 22 April vacated class certification in a lawsuit alleging that GlaxoSmithKline and Teva suppressed generic competition to Lamictal, an anticonvulsant used to treat epilepsy and bipolar disorder. White & Case partner Michael Hamburger, senior associate Adam Acosta and associate Gina Chiappetta analyse how the appellate court’s decision fits into a broader trend of courts clamping down on class certification in …

First in the nation

Amid steady consolidation and weak commodity prices in the agricultural industry, some Democrats are trying to bring trust-busting to centre stage. Spencer Parts zeroes in on the scene in Iowa – the first state to vote on contenders in presidential primaries.

Illumina/PacBio: killing a killer acquisition, or the birth of nascent competition enforcement?

Coordinated action taken by the US Federal Trade Commission and the UK Competition and Markets Authority against Illumina’s proposed acquisition of Pacific Biosciences indicates that both antitrust enforcers are significantly increasing their focus on deals involving nascent competition. Other agencies are likely to follow suit. Crowell & Moring partners Alexis Gilman, Sean-Paul Brankin, Olivier Antoine, and associates Evi Mattioli and Eric Ashby look at the aggressive enforcement theories behind scrutiny …

Global Competition Review makes sense of the competition community and has been providing trusted intelligence for over 20 years.

DOJ conditionally clears Anheuser-Busch/Craft Brew Alliance

Ex-JPMorgan trader receives eight-month sentence

Tipline

FTC witnesses defend product market in healthcare merger challenge

Judge dismisses hiQ antitrust claims, but gives time to amend

NY AG: Abuse of dominance standard necessary to bolster weak laws

USA Analysis

A little smoke, but no fire

Analysis: Lamictal highlights increased class action scrutiny in pharma cases

First in the nation

Illumina/PacBio: killing a killer acquisition, or the birth of nascent competition enforcement?

Events

Insight

From the publisher of:

DOJ conditionally clears Anheuser-Busch/Craft Brew Alliance

Ex-JPMorgan trader receives eight-month sentence

Tipline

FTC witnesses defend product market in healthcare merger challenge

Judge dismisses hiQ antitrust claims, but gives time to amend

NY AG: Abuse of dominance standard necessary to bolster weak laws

USA Analysis

A little smoke, but no fire

Analysis: Lamictal highlights increased class action scrutiny in pharma cases

First in the nation

Illumina/PacBio: killing a killer acquisition, or the birth of nascent competition enforcement?

Most read

Events

Insight

From the publisher of: